Clinical Trial

SpO2 Validation Study-Philips Optimus

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
The clinical study was terminated ahead of schedule due to the availability of next-generation devices.
Summary
Validation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-08.
Status change: Completed → Terminated 2026-04-07
Trial Details
NCT Number NCT07215429
Lead Sponsor Philips Clinical & Medical Affairs Global
Conditions Pulse Oximetry, Oxygen Measurements, SpO2
Enrollment 24 participants
Start Date 2025-09-09
Primary Completion 2025-09-19 (estimated)
Study Completion 2025-09-19 (estimated)
Updated on ClinicalTrials.gov 2026-04-13